These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 21178268)
1. Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer. Kohli M; Rothberg PG; Feng C; Messing E; Joseph J; Rao SS; Hendershot A; Sahsrabudhe D Cancer Biomark; 2010; 7(2):101-8. PubMed ID: 21178268 [TBL] [Abstract][Full Text] [Related]
2. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy. Nam RK; Zhang WW; Klotz LH; Trachtenberg J; Jewett MA; Sweet J; Toi A; Teahan S; Venkateswaran V; Sugar L; Loblaw A; Siminovitch K; Narod SA Clin Cancer Res; 2006 Nov; 12(21):6452-8. PubMed ID: 17085659 [TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection. Nam RK; Zhang WW; Trachtenberg J; Diamandis E; Toi A; Emami M; Ho M; Sweet J; Evans A; Jewett MA; Narod SA J Clin Oncol; 2003 Jun; 21(12):2312-9. PubMed ID: 12805332 [TBL] [Abstract][Full Text] [Related]
4. Human kallikrein-2 gene polymorphism is associated with the occurrence of prostate cancer. Chiang CH; Hong CJ; Chang YH; Chang LS; Chen KK J Urol; 2005 Feb; 173(2):429-32. PubMed ID: 15643194 [TBL] [Abstract][Full Text] [Related]
5. The use of genetic markers to determine risk for prostate cancer at prostate biopsy. Nam RK; Zhang WW; Jewett MA; Trachtenberg J; Klotz LH; Emami M; Sugar L; Sweet J; Toi A; Narod SA Clin Cancer Res; 2005 Dec; 11(23):8391-7. PubMed ID: 16322300 [TBL] [Abstract][Full Text] [Related]
6. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457 [TBL] [Abstract][Full Text] [Related]
7. Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate Cancer. Reis ST; Viana NI; Leite KR; Diogenes E; Antunes AA; Iscaife A; Nesrallah AJ; Passerotti CC; Srougi V; Pontes-Junior J; Salles ME; Nahas WC; Srougi M PLoS One; 2016; 11(12):e0166380. PubMed ID: 27906997 [TBL] [Abstract][Full Text] [Related]
8. Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people. Zhang Y; Li P; Xu A; Chen J; Ma C; Sakai A; Xie L; Wang L; Na Y; Kaku H; Xu P; Jin Z; Li X; Guo K; Shen H; Zheng S; Kumon H; Liu C; Huang P Tumour Biol; 2016 May; 37(5):6653-9. PubMed ID: 26646562 [TBL] [Abstract][Full Text] [Related]
9. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Kupelian PA; Katcher J; Levin HS; Klein EA Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility loci associated with prostate cancer progression and mortality. Gallagher DJ; Vijai J; Cronin AM; Bhatia J; Vickers AJ; Gaudet MM; Fine S; Reuter V; Scher HI; Halldén C; Dutra-Clarke A; Klein RJ; Scardino PT; Eastham JA; Lilja H; Kirchhoff T; Offit K Clin Cancer Res; 2010 May; 16(10):2819-32. PubMed ID: 20460480 [TBL] [Abstract][Full Text] [Related]
11. The role of single nucleotide polymorphisms of miRNAs 100 and 146a as prognostic factors for prostate cancer. Camargo JA; Lopes RE; Ferreira GFD; Viana NI; Guimaraes V; Leite KRM; Nahas WC; Srougi M; Antunes AA; Reis ST Int J Biol Markers; 2021 Jun; 36(2):50-56. PubMed ID: 34030497 [TBL] [Abstract][Full Text] [Related]
12. Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancer. Cramer SD; Sun J; Zheng SL; Xu J; Peehl DM Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2451-7. PubMed ID: 18768516 [TBL] [Abstract][Full Text] [Related]
13. Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer. Chatrabnous N; Ghaderi A; Ariafar A; Razeghinia MS; Nemati M; Jafarzadeh A Cytokine; 2019 Jan; 113():221-227. PubMed ID: 30057362 [TBL] [Abstract][Full Text] [Related]
14. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above. Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435 [TBL] [Abstract][Full Text] [Related]
15. Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population? Mittal RD; Mishra DK; Thangaraj K; Singh R; Mandhani A Steroids; 2007 Apr; 72(4):335-41. PubMed ID: 17257635 [TBL] [Abstract][Full Text] [Related]
16. Human tissue Kallikreins: Blood levels and response to radiotherapy in intermediate risk prostate cancer. Nasser NJ; Thoms J; Soosaipillai A; Pintilie M; Wang R; Diamandis EP; Bristow RG Radiother Oncol; 2017 Sep; 124(3):427-432. PubMed ID: 28427756 [TBL] [Abstract][Full Text] [Related]
17. Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction. Kusuda Y; Miyake H; Kurahashi T; Fujisawa M Urol Oncol; 2013 Jul; 31(5):615-21. PubMed ID: 21600799 [TBL] [Abstract][Full Text] [Related]
18. The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer. Perez CA; Chen H; Shyr Y; Courtney R; Zheng W; Cai Q; Hwang M; Jaboin J; Schleicher S; Moretti L; Wills M; Smith JA; Lu B J Urol; 2010 May; 183(5):2062-9. PubMed ID: 20303520 [TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice. Williams SA; Xu Y; De Marzo AM; Isaacs JT; Denmeade SR Prostate; 2010 May; 70(7):788-96. PubMed ID: 20058238 [TBL] [Abstract][Full Text] [Related]
20. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy]. Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]